Home > Boards > US OTC > Cannabis >

Endocan Corp. (ENDO)

Add ENDO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/10/2018 10:59:19 AM - Followers: 163 - Board type: Free - Posts Today: 0

About Endocan Corporation

The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.

Premium quality of life is one of the most rewarding ways to feel great and outright spoil ourselves. The Endocan product line by The Endocan Corporation is a new stage of
innovative cannabinoid-based solutions, with a fresh focus on the health decisions of today. The critical ailments, such as cancer,AIDS/HIV, asthma, glaucoma, influenza,
pain management, & PTSD to more general conditions, such as sunburn and skin dryness, all seem to have a beneficial response to cannabinoids.
Endocan utilizes the unique and potent benefits of cannabinoids; the natural components found in the cannabis plant.
Cannabinoids are the ideal solution due to their organic properties that the body responds extremely well to. Endogenous endocannabinoid system is responsible for
the unique communication pathways in the brain and body affecting many important functions including modulation of the response to disease. Our formulations
target the endocannabinoid system thus affecting the cause, not only the symptoms. Endocan’s motivation to bring superior products to their respective markets is based on the incredible market need for answers to critical ailments and generalconditions.
The personal care market including   cosmeceuticals, nutraceuticals, and anti-aging is one of the largest in the world.


Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.





Corporate Overview

"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."

Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.

Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.

Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.

Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.

Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.

Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.

Endocan is poised to flourish in the retailmarket place. Endocan aims to capture a profitable share of the personal care as well as a portion of the critical ailment markets.Endocan diversifies it product base into more product lines and marketing focuses on Endocan becoming more of a household name.
Endocan’s unique formulations matched with Endocan’s unmatched ability to deliver new and exciting products to the market
enhanced by our branding identity is essential to our success. Our formulations include proprietary extracts
that increase the quality, durability, and effectiveness of the products, especially when compared to other consumer options that currently exist on the shelf.
Sales are illustrated to rise to over $100million dollars over five to ten years as the
company benefits from both global expansion and franchising opportunities.



           About Cannabis & Cannabinoids

About CannabiinoidsThere are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”

Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:


  • Cannabigerols (CBG)
  • Cannabichromenes (CBC)
  • Cannabidiols (CBD)
  • Tetrahydrocannabinols (THC)
  • Cannabinol (CBN) and Cannabinodial (CBDL)
  • Other Cannabinoids

The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”


The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.


A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.

History of Cannabis

The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.

In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.

The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.





Critical Ailments

Endocan develops products for critical ailments.

The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.

Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.

Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:

Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?

Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.


Table: Market Analysis


Market Analysis Chart


Table: Global Potential Customers

Global Potential Customers Chart

Table: Global Potential Customers - Cancer

Global Potential Customers with Cancer Chart





Corporate Profile

Endocan is dedicated to quality, respect for human life, and constant evaluation.

Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.

Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.


Executive Summary

Please click on the document title to download.

Download PDF Document Endocan Corporation 2013 Executive Summary

Endocan Moves Forward With New Product Releases After Successful Brand and Website Launch; Focused Efforts Include Product Distribution Outlets for USA, Canada, and Europe Oct-23-2013
Endocan Corporation (XCHC) is Pleased to Announce the Endocan™ Website Goes Live Today Oct-17-2013
Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan™ on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding to Bring its Medical Cannabis Formulations to Market as its Next Major Corporate Move Oct-14-2013
Endocan Corporation, FKA The X-Change Corp, Motivated by Canadian Government Move; From Huffington Post: 'Canada Medical Marijuana: Health Canada Presides Over Birth Of Billion-Dollar Free Market' Oct-01-2013
XCHC Changes Corporate Name to "Endocan Corporation"; Medical Cannabis Industry-Driven Branding Campaign Begins with Name Change and Continues into the Arizona Dispensary Opening Sep-26-2013
The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website Sep-06-2013
X-Change Corp. Recaps Significant Corporate Activities for Past 15 Days Sep-05-2013
X-Change Corp. Delighted with DOJ's Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees 'Green Light' for Company's Patient-Driven Medical Cannabis Operations Under State Laws Aug-30-2013
X-Change Moves Forward Signing Next Multi-Year Contracts with State-Licensed Medical Cannabis Dispensary in Arizona to Develop, Dispense, Infuse, and Cultivate Products for On-Site, Use of 'Medbox' Technology for Fulfillment, and Distribution Aug-21-2013
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting Aug-20-2013

Management Team

Dr Dorothy Bray, Ph.D.
Director & President
Chad S. Johnson, Esq.
Director, COO &General Counsel
Mario Lap
Director & President of European Operations
Robert Kane
Director, CFO & Sr.VP for Business Development
Alfredo Dupetit
Director & VP European Operations
Drue Young
Vice President of Product Development

Steven B. Hopping, M.D., F.A.C.S.

Board of Advisors, Senior Medical Advisor
Greta Gaines

Board of Advisors, Marketing Specialist
Greta Gaines


Company Stock Symbol
XCHC - View Stock Quote

Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001

Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001

Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENDO News: MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing 08/30/2017 10:29:33 PM
ENDO News: PotNetwork Holdings, Inc Confirmed for MJAC 2017 08/28/2017 10:43:55 AM
ENDO News: MJAC 2017 International Cannabis Conference - Discount Code 08/24/2017 08:40:00 AM
ENDO News: MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market 08/22/2017 01:27:13 AM
#8688   Working on it....Kane needs to pay for his sicofbs 12/07/16 11:20:16 AM
#8687   How has this not been suspended yet? Art Vandeley 12/07/16 09:50:38 AM
#8686   Welcome to the Tips, Complaints and Referrals website. sicofbs 12/05/16 12:13:20 PM
#8685   $ENDO - #Cannabis CandleGlance: http://investo DollarsOnPennies 11/03/16 01:35:21 AM
#8684   How can a public corporation sell products and sicofbs 10/27/16 05:36:31 PM
#8683   Still under radar! UP Trend 10/24/16 10:39:24 AM
#8682   Found $ENDO early... now $SNRY is next makinezmoney 10/21/16 11:20:35 AM
#8681   looking good Gateway_Stocks 10/20/16 02:19:37 PM
#8680   We probably will hit .10 by beg of November Rick026 10/20/16 11:49:51 AM
#8679   Looks like people catching wind of this! UP Trend 10/20/16 09:56:18 AM
#8678   Just a matter of time before they connect UP Trend 10/19/16 02:17:58 PM
#8677   CBIS running will attract attention to ENDO makinezmoney 10/19/16 01:47:09 PM
#8676   Thinning out, nice to see it flying under UP Trend 10/19/16 01:06:56 PM
#8675   Wonder what plays he is invested in. Such UP Trend 10/19/16 11:27:04 AM
#8674   Snoop puts it best. makinezmoney 10/19/16 10:56:16 AM
#8673   Agree, this is totally under people's radar! Going UP Trend 10/19/16 09:50:45 AM
#8672   Damn another winner!! DD goes along way!! UP Trend 10/19/16 09:47:10 AM
#8671   BOOM !!!!!! makinezmoney 10/19/16 09:45:28 AM
#8670   Still largely undiscovered weed play here....... More to go makinezmoney 10/19/16 09:14:19 AM
#8669   on pink limited info and they can't even JohnnyBlaze 10/18/16 11:26:50 PM
#8668   This is gonna go, think it flew under UP Trend 10/18/16 04:37:31 PM
#8667   My bad went to like you got UP Trend 10/18/16 03:36:01 PM
#8666   The website is OmniCanna makinezmoney 10/18/16 03:34:56 PM
#8665   My bad wrong website.. Interesting play! Looks good UP Trend 10/18/16 03:33:10 PM
#8664   Hmmmm website is for sale, do they have UP Trend 10/18/16 03:29:18 PM
#8663   CBIS & OmniCanna Licencing agreement. makinezmoney 10/18/16 11:13:18 AM
#8662   The next Marijuana mover..... $0.20 on Last Major-Move makinezmoney 10/18/16 10:36:04 AM
#8661   The Hempery makinezmoney 10/18/16 10:33:00 AM
#8660   Tried to tell everyone long ago this is sicofbs 10/13/16 10:53:07 AM
#8659   Well. Not a lot going on Vmax1 10/07/16 05:23:47 PM
#8658   $ENDO garbage stock MazelTov 10/05/16 08:38:13 PM
#8657   This hasn't been suspended yet? When was Art Vandeley 09/03/16 11:28:43 AM
#8656   Well it's pretty obvious Greta gaines is in sicofbs 08/22/16 11:28:20 AM
#8655   Who even knows anymore there have been so sicofbs 07/29/16 04:49:14 PM
#8654   Greta and Dorothy quiet as a mouse. Does CBIS U ROCK 07/28/16 09:15:24 PM
#8653   Still no products listed on their site ... sicofbs 07/28/16 07:13:21 PM
#8652   Right now. this scam has 45% difference between Heinekenken 07/14/16 08:19:27 AM
#8651   This pos still trades? HELLO SEC? Art Vandeley 07/12/16 06:53:47 PM
#8650   Another Raymond c Dabney pot scam orchestrated by sicofbs 07/12/16 06:31:39 PM
#8649   This thing still trades? What is the Art Vandeley 04/18/16 10:31:44 PM
#8648   ENDO = Raymond Dabney Scam Inorout 04/14/16 01:08:50 AM
#8647   Take a good look at the news and sicofbs 04/08/16 01:50:20 PM
#8646   Looks to me like Dabney is outa bullets sicofbs 04/04/16 05:53:30 PM
#8645   No because they haven't filed a report in Art Vandeley 03/31/16 12:00:50 AM
#8644   Anybody know the share structure ?? $$$ENDO Leezee Life Strategies 03/24/16 03:45:57 PM
#8643   Go time ;) Elcappy1 03/17/16 04:12:43 PM
#8642   ENDO OmniCanna's Confidence in its Business Model and TPX 03/17/16 04:01:50 PM
#8641   ENDO 0.015 +76.47%! HUGE GREEN!!! Goes up OVER TPX 03/17/16 04:01:02 PM
#8640   Omnicann....Lol...the flagship company....a stock fraud brought to you sicofbs 03/10/16 08:29:39 AM
#8639   OmniCanna Health Solutions Inc. Proudly Announces the Showcasing LongShot_Louie 03/09/16 03:28:40 PM